Raquel Buj
Raquel Buj
Institute of Predictive and Personalized Medicine of Cancer (IMPPC)
Dirección de correo verificada de imppc.org
Citado por
Citado por
DNA methylation profiling of well‐differentiated thyroid cancer uncovers markers of recurrence free survival
V Mancikova, R Buj, E Castelblanco, L Inglada‐Pérez, A Diez, ...
International journal of cancer 135 (3), 598-610, 2014
Deoxyribonucleotide triphosphate metabolism in cancer and metabolic disease
R Buj, KM Aird
Frontiers in endocrinology 9, 177, 2018
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
J Huertas-Martínez, F Court, S Rello-Varona, D Herrero-Martin, ...
Cancer letters 386, 196-207, 2017
Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming
R Buj, CW Chen, ES Dahl, KE Leon, R Kuskovsky, N Maglakelidze, ...
Cell reports 28 (8), 1971-1980. e8, 2019
Increased global DNA hypomethylation in distant metastatic and dedifferentiated thyroid cancer
EN Klein Hesselink, C Zafon, N Villalmanzo, C Iglesias, BM van Hemel, ...
The Journal of Clinical Endocrinology & Metabolism 103 (2), 397-406, 2018
Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples
R Buj, I Mallona, A Díez-Villanueva, V Barrera, D Mauricio, ...
Oncotarget 7 (9), 10536, 2016
A plasmid toolkit for cloning chimeric cDNAs encoding customized fusion proteins into any Gateway destination expression vector
R Buj, N Iglesias, AM Planas, T Santalucía
BMC molecular biology 14 (1), 1-17, 2013
Molecular profiling for acromegaly treatment: a validation study
M Puig-Domingo, J Gil, M Sampedro-Nuñez, M Jordà, SM Webb, G Serra, ...
Endocrine-related cancer 27 (6), 375-389, 2020
Simultaneous isotope dilution quantification and metabolic tracing of deoxyribonucleotides by liquid chromatography high resolution mass spectrometry
R Kuskovsky, R Buj, P Xu, S Hofbauer, MT Doan, H Jiang, A Bostwick, ...
Analytical biochemistry 568, 65-72, 2019
Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic implications
R Buj, I Mallona, A Díez-Villanueva, C Zafon, JL Mate, M Roca, ...
Thyroid 28 (5), 601-612, 2018
Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer
ES Dahl, R Buj, KE Leon, JM Newell, Y Imamura, BG Bitler, NW Snyder, ...
Molecular Cancer Research 17 (8), 1710-1720, 2019
p16: cycling off the beaten path
R Buj, KM Aird
Molecular & cellular oncology 6 (6), e1677140, 2019
Suppression of p16 alleviates the senescence-associated secretory phenotype
R Buj, KE Leon, MA Anguelov, KM Aird
Aging (Albany NY) 13 (3), 3290, 2021
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH producing adenomas
J Gil, M Marqués‐Pamies, M Jordà, C Fajardo‐Montañana, ...
Clinical Endocrinology, 2020
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
KE Leon, R Buj, E Lesko, ES Dahl, CW Chen, YI Kawasawa, ...
bioRxiv, 2020
ATM inhibition drives metabolic adaptation via induction of macropinocytosis
CW Chen, R Buj, ES Dahl, KE Leon, EL Varner, E von Krusenstiern, ...
bioRxiv, 2020
Suppression of p16 increases nucleotide synthesis via mTORC1
R Buj, CW Chen, ES Dahl, KE Leon, R Kuskovsky, N Maglakelidze, ...
BioRxiv, 393876, 2018
Overexpression of oncogenic H-Ras in hTERT-immortalized and SV40-transformed human cells targets replicative and specialized DNA polymerases for depletion
W Tsao, R Buj, KM Aird, JM Sidorova, KA Eckert
Plos one 16 (5), e0251188, 2021
Loss of p16: A Bouncer of the Immunological Surveillance?
KE Leon, NK Tangudu, KM Aird, R Buj
Life 11 (4), 309, 2021
ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells
CW Chen, R Buj, ES Dahl, KE Leon, KM Aird
Heliyon 6 (9), e05097, 2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20